MS lesions halved with antibiotics use

Adding antibiotics to current multiple sclerosis (MS) treatment could help prevent relapses by halving the number of brain lesions formed by the condition, US researchers suggest.

Patients with relapsing-remitting MS are prescribed interferon beta-1a, but many experience relapses and continue to develop areas of damaged brain tissue, say the researchers.

For this latest study, the researchers examined 15 patients with relapsing-remitting MS who had been taking interferon for at least six months but were experiencing symptoms and developing new brain lesions. For four months, participants were given 100mg doxycycline daily with interferon treatment.

They also underwent monthly neurological examinations and MRI brain scans.

The researchers found that the combination treatment had resulted in fewer brain lesions.

The average number of brain lesions decreased from 8.8 per MRI scan to four after antibiotic use was added to the treatment.

Using a scale ranging from 1.5 to 4.5 to measure increasing disability levels, the researchers found that antibiotic treatment reduced disability severity from 3.8 to 2.3.

One patient experienced a relapse and two experienced adverse effects, such as muscle pain because of the combination treatment.

Lead researcher Dr Alireza Minagar, from the Louisiana State University Health Centre, said: 'There is interest in combination therapy in patients with MS to reduce the rates of relapses.

'Oral doxycycline and interferon beta-1a may be effective in patients with MS.'

mailto:sanjay.tanday@haymarket.com

- Live links at http://www.healthcarerepublic.com.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce during past year, but number of partners continues to fall

Slight increase in GP workforce during past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Practices are deluged with work, yet many people still think they are ‘closed’. The...

Start date for COVID-19 booster campaign unclear, vaccines minister admits

Start date for COVID-19 booster campaign unclear, vaccines minister admits

A UK COVID-19 booster campaign could start from September - but could also remain...

BMA demands 'systemic change' after LMC report exposes racism in primary care

BMA demands 'systemic change' after LMC report exposes racism in primary care

Most black, Asian and minority ethnic primary care staff have experienced racism...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...